Program 
  
 

Scientific Programme Schedule

 

Friday, April 20

Saturday, April 21

9:00

 

Session IV:

Neuropharmacology

9:30

10:00

Registration

 

Welcome Coffee

10:30

11:00

Coffee break

11:30

Session IV:

Neuropharmacology

12:00

Welcome Address

12:30

Session I:

Cardiovascular

 

Pharmacology

13:00

Lunch

Poster session

13:30

14:00

Lunch

Session V:

Neuropharmacology

14:30

15:00

Session II:

Cellular Regulatory

 

Systems

15:30

16:00

Closing, Poster Awards

16:30

Poster session

17:00

Coffee

17:30

Session III:

40th Anniversary of

the Latvian Society

of Pharmacology

 

18:00

18:30

Welcome Party

19:00

19:30

20:00

 

 

PROGRAMME
FRIDAY, APRIL 20
10.00-11:30 Registration/Welcome Coffee
OPENING
Conference Chair:  Maija Dambrova (Latvia)
11.00-12:00 Welcome Address: Jānis Stradiņš, Chair of the Senate, Latvian Academy of Sciences (Latvia)
Session I

Cardiovascular

pharmacology

Chairs: Maija Dambrova (Latvia)

Stefan Chlopicki (Poland)

12:00-12:30 PL1. Air polution and heart disease - from genetic changes to pharmacological interventions
Boris Z. Simkhovich, Michael T. Kleinman, Robert A. Kloner (USA)
12.30-13:00 PL2. Experimental pharmacology of endothelium: stimulation of the vascular COX2/PGI2 pathway
Stefan Chlopicki (Poland)
13:00-13:15


OP1. The role of vascular tissue gamma-butyrobetaine and L-carnitine content in angioprotection
Vilskersts Reinis, Kuka Janis, Cirule Helena, Liepinsh Edgars, Dambrova Maija (Latvia)
13:15-13:30 OP2. Effect of anthocyanins on ischemia – induced activation in perfused heart
Kristina Skėmiene, Gintare Rakauskaite, Sonata Trumbeckaite, Julius Liobikas, Vilmante Borutaite (Lithuania)
13:30-14:30 Lunch
Session II
Cellular regulatory systems

Chairs: Boris Simkhovich (USA)

Vilma Borutaite (Lithuania)

14:30-15:00 PL3. Mitochondria as a target for pharmacological preconditioning of the heart
Vilmante Borutaite (Lithuania)
15:00-15:30 PL4. L-carnitine and regulation of cardiac energy metabolism
Maija Dambrova (Latvia)
15:30-15.45 OP3. The role of glucose and fatty acid metabolism in the ischemic heart
Edgars Liepiņš (Latvia)
15.45-16.00 OP4. Multilineage differentiation potential of mesenchymal stem cells derived from human skin
Una Riekstiņa (Latvia)
16:00-17:00 Poster session
Session III The 40th Anniversary of the Latvian Society of Pharmacology
17:00-17:30 PL5. The first forty years of the Latvian Society of Pharmacology
Vija Zaiga Kluša (Latvia)
17:30-18:00 Congratulation Ceremony of the new Honorary Members of the Latvian Society of Pharmacology
Modris Melzobs, Vija Zaiga Kluša, Baiba Jansone (Latvia)
18:00-20:00 Welcome Party

 

SATURDAY, APRIL 21

Session IV
Neuropharmacology

Chairs: Edwin Zvartau (Russia)

Laura Della Corte (Italy)

9:00-9:30 PL6. New mechanims of neuroprotection
Sergey Seredenin (Russia)
9:30-10:00 PL7. Neuroprotection studies in in vivo models of neurodegeneration
Maria Alessandra Colivicchi, Chiara Ballini, Chiara Stefanini, Wolghardt Freinbichler, Irene Bolea, Julie Kelly, Vija Z. Kluša, Gunars Duburs, Keith Francis Tipton, Laura Della Corte (Italy, Austria, Ireland, Latvia)
10.00-10:30 PL8. Dysfunctional brain plasticity and the development of neuropsychiatric disorders
Alexander Zharkovsky, Kristina Malinovskaja, Anu Aonurm-Helm, Monika Jurgenson, Tamara Zharkovsky, Rita Gerardy-Schahn, Birgit Weinhold (Estonia, Germany)
10:30-11:00 Coffee break/Poster presentations
11:00-11:30 PL9. Behavioral pharmacology of nicotine: focus on animal models of addiction and search of novel pharmacotherapies
Edwin Zvartau (Russia)
11:30-12:00 PL10. Neurotrophic factors CDNF  and MANF in experimental models of Parkinson's disease
Raimo K Tuominen, Merja H Voutilainen, Päivi Lindholm, Susanne Bäck, Johan Peränen, Maria Linddahl, Päivi Lindholm, Nisse Kalkkinen, Tõnis Timmusk, Sanna Janhunen, Veli-Matti Leppänen, Jaan-Olle Andressoo, Atso Raasmaja, Pekka T Männistö, Mart Saarma (Finland)
12:00-12:15 OP5. The regulation of imflammatory pathways by the use of taurine prodrugs
Roberta J Ward, Frederic Lallemand, Philippe de Witte, Robert R Crichton, Mike Page, Gunars Duburs, Laura Della Corte, David T Dexter (Belgium, UK, Italy, Latvia)
12.15-12.30 OP6. Investigation into stereoselective pharmacological activity of CNS drugs
Liga Zvejniece (Latvia)
12:30-13:30 Lunch/Poster session
Session V
Neuropharmacology

Chairs: Raimo Tuominen (Finland)

Sergey Seredenin (Russia)

13:30-14:00 PL11. Hypertension and Alzheimer’s disease
Inga Kadish, Grace Balinda, Kym Do and Thomas van Groen (USA)
14:30-15:00 PL12. Design and studies of novel neuroprotectors
Vija Z. Kluša (Latvia)
15:00-15:15 OP7. Application of fluorescence methods for characterization of pharmacological properties of GPCR
Ago Rinken, Sergei Kopanchuk, Olga Mazina, Reet Reinart-Okugbeni,
Santa Veiksina, Indrek Viil (Estonia)
15:15-15:30 OP8. Influence of propargyl- or adamanthyl-group containing 1,4- dihydropyridine derivatives on behaviour in old animals
Baiba Jansone, Jolanta Pupure, Zane Dzirkale, Liene Adlere, Reinis Svarcbahs, Zane Krumina, Nina Karajeva, Brigita Vigante, Aiva Plotniece, Karlis Pajuste, Juris Rumaks, Vallo Matto, Simons Svirskis, Vija Z. Kluša (Latvia)
15:30-15:45 OP9. Distinct effects of mildronate and novel dihydropyridine compound D3-72 in haloperidol-induced rat model of motor abnormalities and cognitive impairment
Sergejs Isajevs, Darja Isajeva, Jolanta Pupure, Juris Rumaks, Baiba Jansone, Ulrika Beitnere, Ivars Kalvinsh, Ruta Muceniece, Vija Z. Kluša (Latvia)
15:45-16:15 Closing, Poster Awards

Poster Award 

Committee

Ruta Muceniece (Latvia)

Boris Z. Simkhovich (USA)

Alexander Zharkovski (Estonia)

16:15-17:00 Coffee

 

OP1. The role of vascular tissue gamma-butyrobetaine and L-carnitine content in angioprotection
Vilskersts Reinis, Kuka Janis, Cirule Helena, Liepinsh Edgars, Dambrova Maija (Latvia)